Atorvastatin Calcium Salt is a selective and competitive HMGCR (HMG-CoA reductase) inhibitor, the rate-controlling enzyme of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. Inhibition of HMG-CoA reductase results in a drastic reduction in the production of cholesterol and other isoprenoids. Competitive inhibitors of the reductase are believed to induce the expression of LDL (Low Density Lipoprotein) receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol.


IUPAC Name (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoicacid
CAS Number 134523-03-8
Molecular Formula C66H68CAF2N4O10
Synonyms Tahor;ci-981;YM-548;Sortis;LIPITOR;pd134298-38a;ATORVASTATIN CA;Atorvastatin 3S,5S-Atorvastatin;Alorvastin calcium
Application The primary uses of atorvastatin is for the treatment of dyslipidemia and the prevention of cardiovascular disease. 
Note — API/Substances covered by patents are not offered to the countries where valid Patent Law is in force. However, the final responsibility lies with the customer.